Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05824403

PAncreatic Disease Cohort of TOuLouse

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
University Hospital, Toulouse · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

This study is a prospective cohort dedicated to pancreatic diseases excluding cancer. The aim is to develop positive or differential diagnostic tools between benign potentially malignant or malignant pancreatic pathologies. During this study the investigators collect data and biological samples to support research project.

Detailed description

This collection focuses on pathology of the pancreas requiring specific investigations or management for diagnosis or treatment. Pancreatic pathologies can be classified as malignant, potentially malignant or benign tumors. These can be solid or cystic. There is an inflammatory attack on the pancreas, generating acute pancreatitis in the acute period, if the inflammatory manifestations persist, chronic pancreatitis will develop. Some lesions may be at risk of malignancy during their evolution, it is therefore necessary to improve the performance of monitoring and diagnostic tools in order to adapt the management of patients.

Conditions

Timeline

Start date
2023-11-28
Primary completion
2027-12-01
Completion
2027-12-01
First posted
2023-04-21
Last updated
2023-12-04

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05824403. Inclusion in this directory is not an endorsement.